File(s) not publicly available
Developments and current pharmacotherapeutic recommendations for ankylosing spondylitis
journal contributionposted on 2023-05-16, 20:40 authored by Zochling, JM, Braun, J
The introduction of anti-TNFÎ± therapy into the field of rheumatology has led to dramatic improvements in patient care, perhaps the most remarkable being in the management of ankylosing spondylitis. As experience with these compounds grows, their place in therapeutic strategy is becoming clearer, and it has been possible to develop evidence- and expertise-based recommendations for the management of ankylosing spondylitis to aid the clinician in patient care. This review outlines treatment advances in ankylosing spondylitis, including the use of anti-TNFÎ± agents, and how these have been incorporated into clinical recommendations for daily use. Â© 2006 Informa UK Ltd.
Publication titleExpert opinion on pharmacotherapy
Department/SchoolMenzies Institute for Medical Research
PublisherAshley Publications Ltd
Place of publicationUnitec House, 3Rd Fl, 2 Albert Place, Finchley Central, London, England, N3 1Qb